Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Nymox Pharmaceutical stock

Learn how to easily invest in Nymox Pharmaceutical stock.

Nymox Pharmaceutical Corp is a biotechnology business based in the US. Nymox Pharmaceutical shares (NYMX) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Nymox Pharmaceutical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NYMX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Nymox Pharmaceutical stock price (NASDAQ: NYMX)

Use our graph to track the performance of NYMX stocks over time.

Nymox Pharmaceutical shares at a glance

Information last updated 2022-07-02.
Latest market close$0.41
52-week range$0.35 - $2.27
50-day moving average $0.81
200-day moving average $1.39
Wall St. target price$10.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.18

Buy Nymox Pharmaceutical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Nymox Pharmaceutical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nymox Pharmaceutical price performance over time

Historical closes compared with the close of $0.41 from 2022-07-01

1 week (2022-06-24) -8.89%
1 month (2022-06-02) 5.13%
3 months (2022-04-01) -66.39%
6 months (2021-12-31) -68.46%
1 year (2021-07-02) -73.89%
2 years (2020-07-02) -88.80%
3 years (2019-07-02) 1.51
5 years (2017-06-30) 4.4

Nymox Pharmaceutical financials

Gross profit TTM $1,000
Return on assets TTM -703.17%
Return on equity TTM -1529.83%
Profit margin 0%
Book value $0.02
Market capitalisation $37 million

TTM: trailing 12 months

Nymox Pharmaceutical share dividends

We're not expecting Nymox Pharmaceutical to pay a dividend over the next 12 months.

Nymox Pharmaceutical share price volatility

Over the last 12 months, Nymox Pharmaceutical's shares have ranged in value from as little as $0.35 up to $2.27. A popular way to gauge a stock's volatility is its "beta".

NYMX.US volatility(beta: 1.14)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nymox Pharmaceutical's is 1.1402. This would suggest that Nymox Pharmaceutical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Nymox Pharmaceutical overview

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas. .

Frequently asked questions

What percentage of Nymox Pharmaceutical is owned by insiders or institutions?
Currently 45.151% of Nymox Pharmaceutical shares are held by insiders and 1.43% by institutions.
When does the fiscal year end for Nymox Pharmaceutical?
Nymox Pharmaceutical's fiscal year ends in December.
Where is Nymox Pharmaceutical based?
Nymox Pharmaceutical's address is: Bay & Deveaux Streets, Nassau, Bahamas
What is Nymox Pharmaceutical's ISIN number?
Nymox Pharmaceutical's international securities identification number is: BSP733981026
What is Nymox Pharmaceutical's CUSIP number?
Nymox Pharmaceutical's Committee on Uniform Securities Identification Procedures number is: 670768100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site